QuantaMatrix Inc.
QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early dia… Read more
QuantaMatrix Inc. (317690) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.640x
Based on the latest financial reports, QuantaMatrix Inc. (317690) has a cash flow conversion efficiency ratio of -0.640x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.46 Billion) by net assets (₩6.96 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
QuantaMatrix Inc. - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how QuantaMatrix Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
QuantaMatrix Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of QuantaMatrix Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SUN KWANG CO.Ltd
KQ:003100
|
0.038x |
|
Atturra Ltd
AU:ATA
|
0.054x |
|
Urja Global Limited
NSE:URJA
|
-0.086x |
|
NAU IB Capital
KQ:293580
|
-0.026x |
|
I-Tech
ST:ITECH
|
0.072x |
|
Chi Sheng Chemical
TWO:4111
|
0.013x |
|
Qua Granite Hayal Yapi ve Urunleri Sanayi Ticaret AS
IS:QUAGR
|
-0.007x |
|
DK-Lok Corporation
KQ:105740
|
0.012x |
Annual Cash Flow Conversion Efficiency for QuantaMatrix Inc. (2017–2024)
The table below shows the annual cash flow conversion efficiency of QuantaMatrix Inc. from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩6.53 Billion | ₩-12.93 Billion | -1.981x | -73.71% |
| 2023-12-31 | ₩18.12 Billion | ₩-20.66 Billion | -1.140x | -174.10% |
| 2022-12-31 | ₩39.88 Billion | ₩-16.59 Billion | -0.416x | -61.97% |
| 2021-12-31 | ₩58.39 Billion | ₩-15.00 Billion | -0.257x | -11.58% |
| 2020-12-31 | ₩57.40 Billion | ₩-13.21 Billion | -0.230x | +53.37% |
| 2019-12-31 | ₩29.28 Billion | ₩-14.45 Billion | -0.494x | -345.47% |
| 2018-12-31 | ₩-40.23 Billion | ₩-8.09 Billion | 0.201x | +6.48% |
| 2017-12-31 | ₩-26.67 Billion | ₩-5.04 Billion | 0.189x | -- |